Phyto Chem (India) (BSE 524808)₹17.49+1.75%Pesticides & Agrochemicals
In the Mar 2026 quarter (standalone), Phyto Chem (India) reported sales of ₹0.24 Cr, down 83.7% from Mar 2025, and net profit of −₹0.27 Cr. For the year to Mar 2026, sales were ₹9.09 Cr and net profit −₹1.79 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.65 | 7.23 | 6.53 | 0.46 | 4.62 | 4.38 | 3.66 | 1.47 | 1.51 | 4.37 | 2.98 | 0.24 |
| Expenses | 1.90 | 6.66 | 5.75 | 3.73 | 5.62 | 3.82 | 3.47 | 2.52 | 2.01 | 4.79 | 3.21 | 0.88 |
| Operating Profit | −1.28 | 0.55 | 0.76 | −3.30 | −1.03 | 0.57 | 0.18 | −1.06 | −0.53 | −0.45 | −0.26 | −0.67 |
| OPM % | −198.3% | 7.6% | 11.6% | −731.1% | −22.0% | 12.9% | 4.7% | −71.9% | −34.6% | −10.0% | −8.4% | −286.9% |
| Other Income | 0.14 | 0.00 | 0.06 | 2.08 | 0.00 | 0.00 | 1.93 | 0.50 | 0.39 | 0.30 | 0.30 | 0.81 |
| Interest | 0.55 | 0.62 | 0.43 | 0.41 | 0.37 | 0.37 | 0.51 | 0.56 | 0.32 | 0.34 | 0.46 | 0.35 |
| Depreciation | 0.09 | 0.09 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 |
| Profit before tax | −1.75 | −0.15 | 0.27 | −1.70 | −1.46 | 0.10 | 1.50 | −1.18 | −0.53 | −0.56 | −0.49 | −0.28 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | −0.7% | 0.0% | −0.7% | −3.3% | −9.2% | −1.7% | −2.0% | −3.4% |
| Net Profit | −1.75 | −0.15 | 0.28 | −1.70 | −1.46 | 0.10 | 1.51 | −1.15 | −0.47 | −0.55 | −0.47 | −0.27 |
| EPS (Rs) | −4.10 | −0.38 | 0.68 | −3.99 | −3.43 | 0.27 | 3.54 | −2.71 | −1.13 | −1.31 | −1.13 | −0.66 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.81 | 44.52 | 59.00 | 59.21 | 44.26 | 44.58 | 23.16 | 26.81 | 14.78 | 14.10 | 9.09 | 9.10 |
| Expenses | 20.25 | 41.59 | 56.73 | 56.64 | 42.29 | 42.26 | 21.71 | 24.15 | 18.01 | 15.43 | 10.92 | 10.89 |
| Operating Profit | 1.54 | 2.88 | 2.16 | 2.44 | 1.93 | 2.22 | 1.43 | 2.61 | −3.28 | −1.35 | −1.87 | −1.91 |
| OPM % | 7.1% | 6.5% | 3.7% | 4.1% | 4.4% | 5.0% | 6.2% | 9.8% | −22.1% | −9.5% | −20.5% | −21.0% |
| Other Income | 0.67 | 0.26 | 1.54 | 0.97 | 1.37 | 0.79 | 1.28 | 0.15 | 2.31 | 2.46 | 1.82 | 1.80 |
| Interest | 1.71 | 1.66 | 2.12 | 2.09 | 2.46 | 2.11 | 2.09 | 2.09 | 2.04 | 1.83 | 1.49 | 1.47 |
| Depreciation | 0.32 | 0.32 | 0.37 | 0.41 | 0.42 | 0.44 | 0.42 | 0.41 | 0.35 | 0.35 | 0.35 | 0.40 |
| Profit before tax | 0.17 | 1.15 | 1.20 | 0.90 | 0.41 | 0.45 | 0.19 | 0.25 | −3.33 | −1.04 | −1.86 | −1.86 |
| Tax % | 39.0% | 26.8% | 24.0% | 19.9% | −4.7% | −6.5% | −14.9% | 15.5% | −0.3% | −5.7% | −3.7% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.11 | 0.84 | 0.91 | 0.72 | 0.44 | 0.48 | 0.22 | 0.21 | −3.32 | −0.98 | −1.79 | −1.76 |
| EPS (Rs) | 0.29 | 1.99 | 2.15 | 1.71 | 1.06 | 1.15 | 0.54 | 0.52 | −7.76 | −2.31 | −4.20 | −4.23 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.29 | 4.28 | 4.29 | 4.29 | 4.29 | 4.29 | 4.28 | 4.28 | 4.28 | 4.28 | 4.28 | 4.28 |
| Reserves | 3.47 | 3.59 | 3.99 | 4.51 | 5.11 | 5.54 | 5.86 | 6.12 | 6.29 | 3.05 | 2.08 | 0.26 |
| Borrowings | 15.98 | 16.01 | 18.43 | 18.54 | 22.08 | 22.96 | 21.32 | 21.16 | 19.41 | 18.15 | 15.74 | 20.42 |
| Other Liabilities | 11.86 | 5.60 | 15.16 | 30.16 | 41.26 | 34.70 | 13.84 | 6.75 | 9.89 | 6.13 | 5.70 | 2.98 |
| Total Liabilities | 35.60 | 29.48 | 41.87 | 57.50 | 72.74 | 67.49 | 45.30 | 38.31 | 39.87 | 31.61 | 27.80 | 27.94 |
| Fixed Assets | 3.67 | 3.49 | 3.24 | 4.09 | 4.17 | 4.66 | 3.42 | 3.12 | 2.74 | 2.73 | 2.38 | 2.06 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.10 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.33 | 0.33 | 0.25 | 0.26 | 0.13 | 0.12 | 0.17 | 0.18 | 0.08 | 0.09 | 0.06 | 0.06 |
| Other Assets | 31.60 | 25.66 | 38.38 | 53.05 | 67.98 | 62.71 | 41.71 | 35.01 | 37.05 | 28.79 | 25.36 | 25.82 |
| Inventories | 12.86 | 9.85 | 11.27 | 14.51 | 16.82 | 16.82 | 16.11 | 12.59 | 14.80 | 11.98 | 10.09 | 8.27 |
| Trade receivables | 17.43 | 14.75 | 25.86 | 37.71 | 49.55 | 43.54 | 22.24 | 20.04 | 20.17 | 15.66 | 14.22 | 16.36 |
| Cash & equivalents | 0.45 | 0.23 | 0.17 | 0.15 | 0.18 | 0.17 | 0.12 | 0.13 | 0.06 | 0.15 | 0.04 | 0.01 |
| Total Assets | 35.60 | 29.48 | 41.87 | 57.50 | 72.74 | 67.49 | 45.30 | 38.31 | 39.87 | 31.61 | 27.80 | 27.94 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −2.12 | −0.33 | 1.52 | 0.75 | 1.94 | 1.48 | −0.70 | 3.40 | 1.41 | 3.40 | 1.76 | 0.90 |
| Cash from investing activity | 0.31 | 0.59 | 0.15 | 0.23 | 0.25 | −0.38 | 1.05 | 0.04 | 0.20 | −0.04 | 1.01 | 1.61 |
| Cash from financing activity | 1.80 | −0.49 | −1.77 | −1.03 | −2.20 | −1.11 | −0.41 | −3.46 | −1.71 | −3.27 | −2.92 | −2.57 |
| Net cash flow | −0.03 | −0.24 | −0.07 | −0.02 | 0.03 | −0.02 | −0.06 | 0.02 | −0.08 | 0.11 | −0.13 | −0.03 |
| Capex | 0.03 | 0.19 | 0.08 | 1.29 | 0.86 | 0.45 | 0.18 | 0.10 | 0.02 | 0.33 | 0.00 | 0.03 |
| Free cash flow | −2.18 | −0.49 | 1.47 | −0.55 | 1.12 | 1.05 | 0.45 | 3.31 | 1.45 | 3.16 | 1.80 | 0.91 |
| CFO / OP % | −70.0% | −18.0% | 67.0% | 54.9% | 88.0% | 77.0% | −33.1% | 237.9% | 55.9% | −104.0% | −137.1% | −45.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 157 | 249 | 214 | 235 | 308 | 361 | 184 | 318 | 277 | 389 | 370 | 661 |
| Inventory days | 160 | 261 | 133 | 116 | 129 | 183 | 172 | 342 | 315 | 373 | 338 | 352 |
| Days payable | 113 | 86 | 136 | 176 | 283 | 338 | 110 | 41 | 123 | 91 | 92 | 26 |
| Cash conversion cycle | 201 | 422 | 209 | 173 | 151 | 204 | 244 | 617 | 467 | 670 | 615 | 984 |
| Working capital days | 47 | 103 | 53 | 43 | 44 | 69 | 84 | 154 | 149 | 160 | 129 | 93 |
| ROCE % | 11.9% | 7.7% | 11.1% | 12.3% | 10.1% | 8.9% | 6.9% | 7.2% | 7.5% | −5.0% | 3.3% | −1.6% |
For the Mar 2026 quarter, Phyto Chem (India) reported sales of ₹0.24 Cr, down 83.7% year on year and net profit of −₹0.27 Cr. The operating margin was −286.9%.
Phyto Chem (India)'s sales for the year to Mar 2026 were ₹9.09 Cr; over the last twelve months they were ₹9.10 Cr.
Net profit for the year to Mar 2026 was −₹1.79 Cr, and −₹1.76 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−4.23.
Phyto Chem (India) reported borrowings of ₹20.42 Cr at Mar 2026, against cash and equivalents of ₹0.01 Cr.
Cash from operations was ₹0.90 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.91 Cr.